Positioning system for Dotplot (an at-home breast health monitoring device)

在英国，至少有七分之一的女性会在一生中被诊断出患有乳腺癌，每天有31名女性死于乳腺癌。然而，如果早期诊断，有93%的生存机会，这就是为什么定期乳房自我检查至关重要。不幸的是，妇女往往依赖于示范、辅导和小册子，所有这些都提出了不同的方法。缺乏适当的指导和反馈导致不遵守自我检查。许多女性很难解释她们在乳房中的感觉，因此阻止她们定期检查。Dotplot旨在消除猜测，并鼓励坚持定期。Dotplot是一个面向消费者的家庭乳房健康监测工具，旨在帮助女性自信地照顾自己的乳房。它结合了手持设备和软件，能够阅读，定位和记录乳房健康数据。该公司正在申请专利的技术指导女性每月进行乳房自检，并对乳房组织进行逐月比较。这有助于尽早标记异常的发展，并确保妇女及时到达全科医生那里。创新基金，Dotplot将能够开发其核心功能之一，即定位手持设备在躯干上的位置，并提供在移动的应用程序中提供屏幕反馈和指导。其目的是增强妇女的权能，使她们能够定期关注乳房健康，减少每例乳腺癌的死亡人数。

At least 1 in 7 women in the UK will be diagnosed with breast cancer within their lifetime and 31 women die of it every single day. However, there is a 93% chance of survival if diagnosed early, which is why regular breast self-checks are vital. Unfortunately, women are often dependent on demonstrations, tutorials, and pamphlets, all proposing different methods. Lack of proper guidance and feedback results in non-adherence to self-checks. Many women struggle to interpret what they feel in their breasts hence deterring them from doing regular checks. Dotplot aims to eliminate the guesswork and encourage adherence to a regular routine.Dotplot is a consumer-facing at-home breast health monitoring tool designed to help women look after their breasts with confidence. It combines a handheld device and software that is capable of reading, locating, and recording breast health data. Its patent-pending technology guides women through breast self-checks on a monthly basis and creates month-by-month comparisons of breast tissue. This helps to flag the development of abnormalities as early as possible and ensure women reach their GPs in time.With Innovate UK's Fast Start: Innovation grant, Dotplot will be able to develop one of its core features which is locating the position of the handheld device when held against the torso and providing on-screen feedback and guidance within the mobile application.The aim is to empower women to engage with their breast health on a routine basis and in turn, reduce the number of deaths per incidence of breast cancer.